BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 11:44:00 AM | Browse: 1319 | Download: 1508
 |
Received |
|
2012-08-23 09:53 |
 |
Peer-Review Started |
|
2012-08-23 13:33 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
|
 |
Revised |
|
2012-11-18 13:14 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-02-08 09:35 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-02-08 11:20 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
2013-03-13 10:12 |
 |
Typeset the Manuscript |
|
2013-04-20 13:27 |
 |
Publish the Manuscript Online |
|
2013-05-07 10:53 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Autobiography |
| Article Title |
Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Lian-Zhen Yu, Hai-Yang Wang, Shu-Ping Yang, Zhi-Ping Yuan, Fang-Yuan Xu, Chao Sun and Rui-Hua Shi |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81072692 |
| Natural Science Foundation of Jiangsu Higher Education Institutions of China |
10KJB320007 |
|
| Corresponding Author |
Rui-Hua Shi, MD, PhD, Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, Jiangsu Province, China. ruihuashi@126.com
|
| Key Words |
Ulcerative colitis; Ulcerative colitis-related carcinogenesis; Interleukin-22; Interleukin-22R1; STAT3 |
| Core Tip |
This study investigates the expression of interleukin (IL)-22, IL-22R1, IL-23, and STAT3 in ulcerative colitis (UC) and UC-related carcinogenesis (UC-CRC) tissues from human and mouse. The results showed that IL-22 and related proteins were closely related to the severity of colitis, and the expression level of IL-22 and related proteins was higher in dysplasia tissues. IL-22/STAT3 signaling pathway was related to UC and UC-CRC. IL-22 can be used as a biomarker for determining the severity of UC and as an interesting therapeutic target in active UC and UC-CRC.
|
| Publish Date |
2013-05-07 10:53 |
| Citation |
Yu LZ, Wang HY, Yang SP, Yuan ZP, Xu FY, Sun C, Shi RH. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis. World J Gastroenterol 2013; 19(17): 2638-2649 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i17/2638.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i17.2638 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.